CCL3 and neoplasm: These data is further supported by another study that intratumoral injection with MIP-1α- and Ad-FLT-3L-encoding oncolytic Ad, compared with MIP-1α- and Ad-FLT-3L-encoding replication-incompetent Ad, elicits improved antitumor immune response, implying the pivotal contribution of the oncolytic Ads for tumor-specific immunity [51].